These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23870495)

  • 1. Sample size re-assessment leading to a raised sample size does not inflate type I error rate under mild conditions.
    Broberg P
    BMC Med Res Methodol; 2013 Jul; 13():94. PubMed ID: 23870495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications.
    Graf AC; Bauer P; Glimm E; Koenig F
    Biom J; 2014 Jul; 56(4):614-30. PubMed ID: 24753160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive sample size modification in clinical trials: start small then ask for more?
    Jennison C; Turnbull BW
    Stat Med; 2015 Dec; 34(29):3793-810. PubMed ID: 26172385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplicity and flexibility in clinical trials.
    Brannath W; Koenig F; Bauer P
    Pharm Stat; 2007; 6(3):205-16. PubMed ID: 17674349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for flexible sample-size design in clinical trials: Likelihood, weighted, dual test, and promising zone approaches.
    Shih WJ; Li G; Wang Y
    Contemp Clin Trials; 2016 Mar; 47():40-8. PubMed ID: 26674739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision of maximum likelihood estimation in adaptive designs.
    Graf AC; Gutjahr G; Brannath W
    Stat Med; 2016 Mar; 35(6):922-41. PubMed ID: 26459506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling the type I error rate in two-stage sequential adaptive designs when testing for average bioequivalence.
    Maurer W; Jones B; Chen Y
    Stat Med; 2018 May; 37(10):1587-1607. PubMed ID: 29462835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look.
    Graf AC; Bauer P
    Stat Med; 2011 Jun; 30(14):1637-47. PubMed ID: 21495058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional estimation in two-stage adaptive designs.
    Broberg P; Miller F
    Biometrics; 2017 Sep; 73(3):895-904. PubMed ID: 28099993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential monitoring of covariate adaptive randomized clinical trials with sample size re-estimation.
    Yu J; Lai D
    Contemp Clin Trials; 2019 Dec; 87():105874. PubMed ID: 31678412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I error in sample size re-estimations based on observed treatment difference.
    Shun Z; Yuan W; Brady WE; Hsu H
    Stat Med; 2001 Feb; 20(4):497-513. PubMed ID: 11223896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive blinded sample size adjustment for comparing two normal means--a mostly Bayesian approach.
    Hartley AM
    Pharm Stat; 2012; 11(3):230-40. PubMed ID: 22422722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size re-estimation for pivotal clinical trials.
    Liu Y; Xu H
    Contemp Clin Trials; 2021 Mar; 102():106215. PubMed ID: 33217555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations.
    Kunz CU; Stallard N; Parsons N; Todd S; Friede T
    Biom J; 2017 Mar; 59(2):344-357. PubMed ID: 27886393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.